Recently, OR51E2 [prostate-specific G-protein coupled receptor (PSGR)] was found to be overexpressed in prostate cancer tissues (12), and it accelerates prostate cancer development together with the loss of PTEN in a mouse model (13). Here, OR51E2 is linked to prostate cancer.